Human COL9A2/DJ39G22.4/EDM2 ORF/cDNA clone-Lentivirus particle (NM_001852)

Cat. No.: vGMLP001767

Pre-made Human COL9A2/DJ39G22.4/EDM2 Lentiviral expression plasmid for COL9A2 lentivirus packaging, COL9A2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to COL9A2/DJ39G22.4 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP001767 Human COL9A2 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP001767
Gene Name COL9A2
Accession Number NM_001852
Gene ID 1298
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 2070 bp
Gene Alias DJ39G22.4,EDM2,MED,STL5
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCCGCCGCTACGGCCTCCCCCCGCAGCCTCCTTGTTCTCCTCCAGGTGGTAGTGCTCGCTCTGGCGCAGATTAGAGGTCCACCGGGAGAGCGGGGCCCCCCGGGTCCCCCGGGACCGCCGGGAGTGCCTGGATCCGACGGCATCGACGGTGACAATGGGCCCCCTGGAAAAGCTGGCCCTCCGGGACCCAAGGGCGAGCCTGGCAAAGCTGGGCCAGATGGGCCAGACGGGAAGCCCGGGATTGATGGTTTAACTGGAGCCAAGGGGGAGCCTGGCCCCATGGGGATCCCTGGAGTCAAGGGCCAGCCCGGGCTTCCTGGTCCTCCTGGCCTTCCGGGCCCTGGTTTTGCTGGACCTCCTGGGCCTCCTGGACCTGTTGGCCTCCCTGGTGAGATTGGAATCCGAGGCCCCAAGGGGGACCCTGGACCAGATGGACCATCGGGGCCCCCAGGACCCCCTGGGAAACCTGGTCGCCCGGGAACCATCCAGGGTCTGGAAGGCAGTGCGGATTTCCTGTGTCCAACCAACTGTCCACCCGGAATGAAAGGTCCCCCAGGGCTGCAGGGAGTGAAGGGGCATGCGGGCAAACGCGGGATTCTGGGTGATCCTGGCCACCAGGGGAAGCCGGGTCCCAAGGGAGATGTGGGTGCCTCTGGAGAGCAAGGCATCCCTGGACCACCGGGTCCCCAGGGCATCAGGGGCTACCCAGGCATGGCAGGGCCCAAGGGAGAGACGGGCCCTCATGGATATAAAGGCATGGTGGGCGCTATCGGTGCCACTGGGCCACCGGGTGAGGAAGGTCCTAGGGGACCGCCAGGCCGAGCTGGGGAGAAGGGTGACGAGGGCAGCCCAGGTATTCGTGGACCCCAGGGGATCACAGGCCCGAAAGGAGCAACGGGCCCCCCAGGCATCAACGGCAAGGATGGGACCCCAGGCACGCCTGGCATGAAGGGCAGTGCAGGACAGGCGGGACAGCCCGGAAGTCCAGGCCACCAGGGCCTAGCGGGTGTGCCAGGCCAGCCTGGGACAAAAGGAGGCCCTGGAGACCAGGGTGAGCCGGGCCCGCAGGGCCTTCCTGGATTCTCTGGTCCCCCTGGGAAAGAGGGAGAGCCAGGGCCTCGAGGAGAAATTGGTCCCCAGGGCATCATGGGACAGAAGGGTGACCAAGGCGAGAGGGGTCCAGTGGGGCAACCAGGCCCTCAGGGAAGGCAGGGCCCTAAGGGGGAGCAGGGCCCCCCCGGAATTCCAGGGCCCCAAGGCTTGCCAGGCGTCAAAGGAGACAAGGGCTCCCCAGGGAAGACCGGGCCCCGCGGCAAAGTGGGTGACCCAGGGGTGGCCGGCCTCCCCGGAGAGAAAGGCGAGAAGGGCGAGTCCGGCGAGCCGGGGCCCAAGGGACAGCAAGGAGTACGTGGAGAACCCGGCTACCCTGGCCCCAGCGGGGATGCGGGCGCCCCAGGGGTTCAGGGCTACCCTGGTCCCCCCGGCCCTCGAGGACTGGCCGGGAACCGAGGCGTGCCAGGACAGCCCGGGAGACAGGGCGTGGAGGGCCGGGATGCCACTGACCAGCACATCGTGGATGTGGCGCTGAAGATGCTGCAAGAGCAACTGGCAGAGGTCGCCGTGAGTGCCAAGCGGGAAGCCCTGGGTGCGGTGGGCATGATGGGTCCTCCAGGACCTCCTGGGCCCCCTGGGTACCCAGGCAAGCAGGGCCCCCATGGGCACCCTGGCCCTCGGGGCGTTCCTGGCATCGTGGGAGCCGTGGGTCAGATCGGCAACACGGGGCCCAAGGGAAAACGTGGAGAGAAGGGTGATCCAGGAGAAGTGGGACGGGGGCACCCCGGGATGCCTGGGCCCCCAGGGATCCCAGGACTCCCTGGCCGGCCTGGCCAGGCAATCAACGGCAAGGATGGAGATCGAGGGTCCCCAGGGGCTCCAGGAGAGGCAGGTCGACCTGGCCTGCCAGGCCCCGTGGGGCTGCCGGGCTTCTGTGAACCTGCCGCCTGCCTTGGAGCTTCGGCCTATGCCTCTGCCCGCCTTACAGAGCCTGGATCCATCAAGGGGCCTTGA
ORF Protein Sequence MAAATASPRSLLVLLQVVVLALAQIRGPPGERGPPGPPGPPGVPGSDGIDGDNGPPGKAGPPGPKGEPGKAGPDGPDGKPGIDGLTGAKGEPGPMGIPGVKGQPGLPGPPGLPGPGFAGPPGPPGPVGLPGEIGIRGPKGDPGPDGPSGPPGPPGKPGRPGTIQGLEGSADFLCPTNCPPGMKGPPGLQGVKGHAGKRGILGDPGHQGKPGPKGDVGASGEQGIPGPPGPQGIRGYPGMAGPKGETGPHGYKGMVGAIGATGPPGEEGPRGPPGRAGEKGDEGSPGIRGPQGITGPKGATGPPGINGKDGTPGTPGMKGSAGQAGQPGSPGHQGLAGVPGQPGTKGGPGDQGEPGPQGLPGFSGPPGKEGEPGPRGEIGPQGIMGQKGDQGERGPVGQPGPQGRQGPKGEQGPPGIPGPQGLPGVKGDKGSPGKTGPRGKVGDPGVAGLPGEKGEKGESGEPGPKGQQGVRGEPGYPGPSGDAGAPGVQGYPGPPGPRGLAGNRGVPGQPGRQGVEGRDATDQHIVDVALKMLQEQLAEVAVSAKREALGAVGMMGPPGPPGPPGYPGKQGPHGHPGPRGVPGIVGAVGQIGNTGPKGKRGEKGDPGEVGRGHPGMPGPPGIPGLPGRPGQAINGKDGDRGSPGAPGEAGRPGLPGPVGLPGFCEPAACLGASAYASARLTEPGSIKGP

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-SE0806-Ab Anti-CO9A2/ COL9A2/ DJ39G22.4 functional antibody
    Target Antigen GM-Tg-g-SE0806-Ag COL9A2 protein
    ORF Viral Vector pGMLP001767 Human COL9A2 Lentivirus plasmid
    ORF Viral Vector vGMLP001767 Human COL9A2 Lentivirus particle


    Target information

    Target ID GM-SE0806
    Target Name COL9A2
    Gene ID 1298, 12840, 694248, 362584, 101090632, 607609, 505942, 100009713
    Gene Symbol and Synonyms Col9a-2,COL9A2,DJ39G22.4,EDM2,MED,STL5
    Uniprot Accession Q14055
    Uniprot Entry Name CO9A2_HUMAN
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Not Available
    Disease Juvenile arthritis
    Gene Ensembl ENSG00000049089
    Target Classification Not Available

    This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.